Evidence map›Paper›PMID 24270162›Full record

ArticleStem cell research2014

Transcriptional targets of Foxd3 in murine ES cells.

Jennifer L Plank, Michael T Suflita, Cristi L Galindo, Patricia A Labosky

Open access · hybridAbstract read
In one paragraph

Article in Stem cell research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. CHD8 dosage regulates transcription in pluripotency and early murine neural differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Tumor suppression function of FoxD3 in lung cancer.Irish journal of medical science · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jennifer L PlankDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA; Center for Stem Cell Biology, Vanderbilt University, Nashville, TN, USA. Electronic address: jennifer.plank@nih.gov.
Michael T SuflitaDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA; Center for Stem Cell Biology, Vanderbilt University, Nashville, TN, USA.
Cristi L GalindoDepartment of Medicine, Vanderbilt University, Nashville, TN, USA.
Patricia A LaboskyDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA; Center for Stem Cell Biology, Vanderbilt University, Nashville, TN, USA.
Vanderbilt University · US

Funding

UNDERSTANDING MECHANISMS OF hESC SELF-RENEWAL AND CELL FATE COMMITMENTP01GM085354 · NIGMS · UNIVERSITY OF GEORGIA · PI GILBERT, DAVID M · 2008 to 2018
$18.3M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Optimizing Cardiovascular Stem Cells for Cardiac Repair and RegenerationU01HL100398 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HATZOPOULOS, ANTONIS · 2009 to 2015
$8.0M
Neural crest formation and maintenance of multipotencyR01HD036720 · NICHD · VANDERBILT UNIVERSITY · PI LABOSKY, PATRICIA A · 1999 to 2009
$2.9M
Reproductive Biology: Training for the 21st CenturyT32HD007043 · NICHD · VANDERBILT UNIVERSITY · PI OSTEEN, KEVIN G · 1985 to 2011
$2.3M
The anti-fibrotic effects of neuregulin in the heartK01HL121045 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GALINDO, CRISTI LARA · 2014 to 2018
$747k
American Heart Association-American Stroke Association 10PRE4500024NHLBI NIH HHS K01 HL121045NHLBI NIH HHS U01 HL100398NHLBI NIH HHS U01HL100398NICHD NIH HHS R01 HD036720NICHD NIH HHS R01HD036720NICHD NIH HHS T32 HD007043NICHD NIH HHS T32HD007043NIDDK NIH HHS T32 DK007563NIGMS NIH HHS 5P01GM085354NIGMS NIH HHS P01 GM085354
6 · The paper itself

Abstract

Understanding gene regulatory networks controlling properties of pluripotent stem cells will facilitate development of stem cell-based therapies. The transcription factor Foxd3 is critical for maintenance of self-renewal, survival, and pluripotency in murine embryonic stem cells (ESCs). Using a conditional deletion of Foxd3 followed by gene expression analyses, we demonstrate that genes required for several developmental processes including embryonic organ development, epithelium development, and epithelial differentiation were misregulated in the absence of Foxd3. Additionally, we identified 6 novel targets of Foxd3 (Sox4, Safb, Sox15, Fosb, Pmaip1 and Smarcd3). Finally, we present data suggesting that Foxd3 functions upstream of genes required for skeletal muscle development. Together, this work provides further evidence that Foxd3 is a critical regulator of murine development through the regulation of lineage specific differentiation.

Indexed as

AnimalsCell DifferentiationCell LineChromatin ImmunoprecipitationChromosomal Proteins, Non-HistoneCluster AnalysisEmbryonic Stem CellsForkhead Transcription FactorsGene Expression Regulation, DevelopmentalMatrix Attachment Region Binding ProteinsMiceMuscle ProteinsMuscle, SkeletalProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-fosRepressor ProteinsChromosomal Proteins, Non-HistoneForkhead Transcription FactorsFosb protein, mouseFoxd3 protein, mouseMatrix Attachment Region Binding ProteinsMuscle ProteinsPmaip1 protein, mouseProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-fosRepressor ProteinsSmarcd3 protein, mouseSox15 protein, mouseSox4 protein, mouseSOXC Transcription FactorsSOX Transcription Factors

Identifiers

PMID24270162
PMCPMC3934354
OpenAlexW2038186949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.